Robert LeBoyer
Stock Analyst at Noble Capital Markets
(1.72)
# 3,181
Out of 4,761 analysts
17
Total ratings
33.33%
Success rate
3.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRB Nutriband | Initiates: Outperform | $13 | $7.38 | +76.15% | 1 | Jan 22, 2025 | |
| GOVX GeoVax Labs | Maintains: Outperform | $6 → $10 | $1.63 | +513.50% | 2 | Aug 19, 2024 | |
| UNCY Unicycive Therapeutics | Initiates: Outperform | $6 | $0.61 | +883.77% | 1 | Feb 14, 2024 | |
| CVKD Cadrenal Therapeutics | Initiates: Outperform | $60 | $19.23 | +212.09% | 1 | Dec 18, 2023 | |
| ELDN Eledon Pharmaceuticals | Initiates: Outperform | $10 | $4.34 | +130.41% | 1 | Sep 27, 2023 | |
| MAIA MAIA Biotechnology | Initiates: Outperform | $14 | $1.90 | +636.84% | 1 | Feb 21, 2023 | |
| TNXP Tonix Pharmaceuticals Holding | Initiates: Outperform | $384,000 | $9.67 | +3,970,944.47% | 1 | Apr 18, 2022 | |
| LCTX Lineage Cell Therapeutics | Initiates: Outperform | $8 | $0.69 | +1,053.57% | 2 | Aug 19, 2021 | |
| PSTV Plus Therapeutics | Initiates: Buy | $120 | $1.20 | +9,900.83% | 1 | Jan 25, 2021 | |
| BNTC Benitec Biopharma | Downgrades: Neutral | n/a | $11.57 | - | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $8.68 | +38.25% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16,500 | $0.08 | +21,999,900.00% | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.89 | - | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.20 | +257.14% | 2 | Mar 8, 2018 |
Nutriband
Jan 22, 2025
Initiates: Outperform
Price Target: $13
Current: $7.38
Upside: +76.15%
GeoVax Labs
Aug 19, 2024
Maintains: Outperform
Price Target: $6 → $10
Current: $1.63
Upside: +513.50%
Unicycive Therapeutics
Feb 14, 2024
Initiates: Outperform
Price Target: $6
Current: $0.61
Upside: +883.77%
Cadrenal Therapeutics
Dec 18, 2023
Initiates: Outperform
Price Target: $60
Current: $19.23
Upside: +212.09%
Eledon Pharmaceuticals
Sep 27, 2023
Initiates: Outperform
Price Target: $10
Current: $4.34
Upside: +130.41%
MAIA Biotechnology
Feb 21, 2023
Initiates: Outperform
Price Target: $14
Current: $1.90
Upside: +636.84%
Tonix Pharmaceuticals Holding
Apr 18, 2022
Initiates: Outperform
Price Target: $384,000
Current: $9.67
Upside: +3,970,944.47%
Lineage Cell Therapeutics
Aug 19, 2021
Initiates: Outperform
Price Target: $8
Current: $0.69
Upside: +1,053.57%
Plus Therapeutics
Jan 25, 2021
Initiates: Buy
Price Target: $120
Current: $1.20
Upside: +9,900.83%
Benitec Biopharma
Oct 5, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.57
Upside: -
Sep 28, 2020
Initiates: Buy
Price Target: $12
Current: $8.68
Upside: +38.25%
Aug 24, 2020
Initiates: Buy
Price Target: $16,500
Current: $0.08
Upside: +21,999,900.00%
Apr 10, 2018
Downgrades: Neutral
Price Target: n/a
Current: $20.89
Upside: -
Mar 8, 2018
Initiates: Buy
Price Target: $15
Current: $4.20
Upside: +257.14%